Full video transcriptClick to expand
Auto-generated transcript of @yo_talks's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'll take MK-677, like why would you take this?
- 0:03Actually, like in the big 2026, first of all, what is MK-677?
- 0:07Basically, a mimics ghrelin, which is your hunger hormone makes you feel hungry, and it increases
- 0:12your GH and IGF-1 levels.
- 0:14Tense and mimics the hormone that makes you feel hungrier, you're gonna feel hungrier.
- 0:18And like, why do you need that dude?
- 0:19Boking's flipping vaulted dude.
- 0:21I have a thing that leads to my loss, like when we have like one study that's even
- 0:24kind of on this topic, and what they found was after taking it for two years dude,
- 0:30they saw on average a 0.8 kg increase in fat free mass.
- 0:35It doesn't even mean muscle match, it just means fat free mass.
- 0:38Less than two pounds for you American folk, and that's not taking into account waterway,
- 0:43like wanting to eat more food volume, like there's also potential side effects from
- 0:47having increased growth hormone levels.
- 0:48Like, don't do this dude, like why would you lose your nanny card over something
- 0:53as stupid as MK bro?
- 0:55Like, go big or go home dude, what are you doing here dude?
- 0:58I know this is all social construct and stuff but like...
MK-677 warnings on TikTok: separating real risks from hype
Quick answer
MK-677 is an oral ghrelin receptor agonist that stimulates pulsatile GH secretion and raises IGF-1, but long-term RCT data in older adults shows modest fat-free mass gains of roughly 1-2 kg alongside documented increases in fasting glucose and insulin resistance. The creator's concern about appetite amplification is pharmacologically sound, as ghrelin receptor activation does increase caloric drive. There are no published long-term RCTs in healthy trained adults, which makes definitive efficacy claims for hypertrophy in that population unsupported by current evidence.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 warnings on TikTok: separating real risks from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
MK-677 warnings on TikTok: separating real risks from hype should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "MK-677 warnings on TikTok: separating real risks from hype" from YO. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 is an oral ghrelin receptor agonist that stimulates pulsatile GH secretion and raises IGF-1, but long-term RCT data in older adults shows modest fat-free mass gains of roughly 1-2 kg alongside documented increases in fasting glucose and insulin resistance.
The reason this review is not generic is the source wording and the canonical claim label "peptides don t take mk677 greenscreen y yotalksh hypertrophyb bodybui." In this clip, the useful excerpt is: "I'll take MK-677, like why would you take this?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 is an oral ghrelin receptor agonist that stimulates pulsatile GH secretion and raises IGF-1, but long-term RCT data in older adults shows modest fat-free mass gains of roughly 1-2 kg alongside documented increases in fasting glucose and insulin resistance.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 is an oral ghrelin receptor agonist that stimulates pulsatile GH secretion and raises IGF-1, but long-term RCT data in older adults shows modest fat-free mass gains of roughly 1-2 kg alongside documented increases in fasting glucose and insulin resistance. The creator's concern about appetite amplification is pharmacologically sound, as ghrelin receptor activation does increase caloric drive. There are no published long-term RCTs in healthy trained adults, which makes definitive efficacy claims for hypertrophy in that population unsupported by current evidence.
- The Nass et al. 2008 RCT, the most-cited long-term data, enrolled adults over 60 with low IGF-1, not healthy trained athletes, limiting how far its results generalize.
- MK-677 reliably raises IGF-1 levels, but elevated IGF-1 alone does not produce meaningful muscle hypertrophy in well-nourished adults with adequate protein intake.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Nass et al. 2008 RCT, the most-cited long-term data, enrolled adults over 60 with low IGF-1, not healthy trained athletes, limiting how far its results generalize.
- MK-677 reliably raises IGF-1 levels, but elevated IGF-1 alone does not produce meaningful muscle hypertrophy in well-nourished adults with adequate protein intake.
- Fat-free mass gains measured in studies include water, glycogen, and connective tissue, so reported lean mass numbers overstate actual muscle accrual.
- Nass et al. 2008 found statistically significant increases in fasting blood glucose and insulin resistance over two years of MK-677 use, a metabolic risk worth weighing.
- MK-677 is an oral small molecule, not a peptide, which distinguishes it from injectable ghrelin mimetics and affects its absorption and side effect profile.
- MK-677 is on the WADA prohibited list and is not FDA-approved for any therapeutic indication, meaning its use in competitive athletes carries regulatory consequences.
- The creator's core skepticism is supported by available evidence, but citing a single elderly-population trial as definitive proof against use in all populations is an overreach.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @yo_talks actually say?
The creator's core argument is simple: MK-677 is not worth taking. They describe it as a ghrelin mimetic that raises GH and IGF-1, then lean hard on one study showing "on average a 0.8 kg increase in fat free mass" after two years of use. Their conclusion is blunt: the hunger side effects, water retention, and modest results make it a bad trade-off for physique goals. Fair enough as a starting point.
They also flag that "fat free mass" is not the same as muscle mass, which is actually a sharper distinction than most fitness influencers bother to make. The broader message is that MK-677 is overhyped relative to what the data actually supports for body composition.
Does the science back this up?
Mostly, yes. The study they're referencing is almost certainly Nass et al. (2008, Annals of Internal Medicine), a two-year randomized controlled trial in older adults where MK-677 increased lean body mass by roughly 1-2 kg depending on the subgroup. The creator's 0.8 kg figure is on the lower end of what that paper reported, but the ballpark is defensible.
What the science actually shows is more nuanced. MK-677 does reliably raise IGF-1 and GH pulse amplitude. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed this in healthy elderly subjects. The problem is that "raises GH" does not automatically translate to meaningful muscle hypertrophy in healthy, well-nourished adults. The body composition effects are modest at best, and the Nass trial also found increased fasting glucose and insulin resistance as notable adverse effects. The hunger effect the creator describes is real and documented. Ghrelin mimetics do increase appetite, and in the context of someone already eating to support training, that is not a neutral side effect.
What did they get wrong (or right)?
They got the mechanism right. MK-677 is an oral ghrelin mimetic, not a peptide in the injectable sense, and it does stimulate GH secretion through the ghrelin receptor pathway. Calling it something that "mimics your hunger hormone" is simplified but not wrong.
Where they overstep: leaning on a single study in older adults to dismiss MK-677 for all populations is a stretch. The Nass trial enrolled adults over 60 with low IGF-1. Extrapolating that to a 25-year-old lifter is a methodological problem the creator glosses over. There are also shorter-term studies, like Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism), showing more pronounced GH and IGF-1 responses that could theoretically matter for recovery. The creator is right to be skeptical, but the evidence base is thin in all directions, not just against MK-677.
The water retention point is accurate. Elevated GH does cause sodium and water retention, which inflates lean mass figures on DEXA or hydrostatic weighing.
What should you actually know?
MK-677 is not a peptide in the injectable category. It is a small molecule taken orally, which changes its regulatory and pharmacokinetic profile significantly. It is not FDA-approved for any indication, and it is on the World Anti-Doping Agency prohibited list.
The side effect profile matters more than the creator gives it credit for. Nass et al. specifically reported increased fasting blood glucose and worsening insulin sensitivity over two years. For anyone with metabolic risk factors, that is not a minor footnote. Edema, fatigue, and joint discomfort are also commonly reported. The hunger amplification the creator mentions is real and can meaningfully disrupt dietary adherence in a cut.
- MK-677 reliably raises IGF-1, but raised IGF-1 does not equal increased muscle in healthy adults eating sufficient protein.
- The best available long-term data comes from elderly populations, not trained athletes.
- Water retention can make lean mass gains look larger than they are on body composition scans.
- Insulin resistance is a documented risk with extended use.
- It is not a controlled substance in the US but is banned in competitive sport.
Bottom line on this video
The creator's skepticism is directionally correct. The evidence for MK-677 as a hypertrophy tool in healthy, trained individuals is genuinely weak. Citing a two-year study in older adults and noting that fat-free mass gains were under a kilogram is a reasonable critique. But the video presents this as a settled case when the actual literature is just sparse. There is a difference between "the evidence is bad" and "the evidence is absent," and conflating them makes the argument weaker than it needs to be.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
YO · TikTok creator
12.0K views on this video
Don’t take MK677…#greenscreen #y#yotalksh#hypertrophyb#bodybuildingscience
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the nass et al. 2008 rct, the most-cited long-term data,?
The Nass et al. 2008 RCT, the most-cited long-term data, enrolled adults over 60 with low IGF-1, not healthy trained athletes, limiting how far its results generalize.
What does the video say about mk-677 reliably raises igf-1 levels,?
MK-677 reliably raises IGF-1 levels, but elevated IGF-1 alone does not produce meaningful muscle hypertrophy in well-nourished adults with adequate protein intake.
What does the video say about fat-free mass gains measured in studies include water, glycogen,?
Fat-free mass gains measured in studies include water, glycogen, and connective tissue, so reported lean mass numbers overstate actual muscle accrual.
What does the video say about nass et al. 2008 found statistically significant increases in fasting?
Nass et al. 2008 found statistically significant increases in fasting blood glucose and insulin resistance over two years of MK-677 use, a metabolic risk worth weighing.
What does the video say about mk-677?
MK-677 is an oral small molecule, not a peptide, which distinguishes it from injectable ghrelin mimetics and affects its absorption and side effect profile.
What does the video say about mk-677?
MK-677 is on the WADA prohibited list and is not FDA-approved for any therapeutic indication, meaning its use in competitive athletes carries regulatory consequences.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by YO, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.